Risk factor criteria

Circulation

Volumn 109, Issue 25, 2004, Pages

  Stampfer, Meir J ^a,b   Ridker, Paul M ^a   Dzau, Victor J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Biomarkers; Cardiovascular disease; Risk factors; Surrogate markers

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD40 LIGAND; CELL ADHESION MOLECULE; CHOLESTEROL; D DIMER; FIBRINOGEN; HOMOCYSTEINE; INTERLEUKIN 18; INTERLEUKIN 6; LIPOPROTEIN A; MYELOPEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR; SERUM AMYLOID A; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR;

AGE; BODY MASS; CARDIOVASCULAR RISK; CHRONIC DISEASE; DIABETES MELLITUS; DISEASE MARKER; GENDER; GLUCOSE INTOLERANCE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSURANCE; OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; SMOKING;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; RISK FACTORS; TERMINOLOGY;

EID: 3042710021     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (3)

1. Rothstein WG. Public Health and the Risk Factor: A History of an Uneven Medical Revolution. Rochester: University of Rochester Press; 2003.
2. Kannel WB, Dawber TR, Kagan A, et al. Factors of risk in the development of coronary heart disease: 6-year follow-up experience. The Framingham Study. Ann Intern Med. 1961;55:33-50.
3. Manolio T. Novel risk markers and clinical practice. N Engl J Med. 2003;349:1587-1589.